Chemed (CHE) Gains from Investment Securities (2009 - 2026)

Chemed (CHE) has reported Gains from Investment Securities for 18 consecutive years, with $1.5 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Gains from Investment Securities rose 427.4% year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at $2.1 million (up 140.57% YoY), while the FY2025 annual figure was $888000.0, up 201.02% from the prior year.
• Gains from Investment Securities came in at $1.5 million for Q1 2026 at Chemed, up from -$7.6 million in the prior quarter.
• The five-year high for Gains from Investment Securities was $12.4 million in Q3 2022, with the low at -$11.6 million in Q4 2022.
• Average Gains from Investment Securities over 5 years is $818750.0, with a median of $881500.0 recorded in 2025.
• Across the five-year window, Gains from Investment Securities slumped 1657.51% in 2022 and jumped 6337.59% in 2024, its largest moves.
• Year by year, Gains from Investment Securities stood at -$11.6 million in 2022, then soared by 135.38% to $4.1 million in 2023, then slumped by 307.54% to -$8.5 million in 2024, then grew by 10.97% to -$7.6 million in 2025, then soared by 119.51% to $1.5 million in 2026.
• According to Business Quant data, Gains from Investment Securities over the past three periods registered $1.5 million, -$7.6 million, and $8.2 million for Q1 2026, Q4 2025, and Q2 2025 respectively.